|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:trimethoprim-sulfamethoxazole
gptkb:Prilosec_OTC
|
|
gptkbp:activities
|
sodium channel blocker
|
|
gptkbp:appointed_by
|
injection
oral tablet
|
|
gptkbp:brand
|
gptkb:Dilantin
gptkb:Phenytek
|
|
gptkbp:category
|
gptkb:D
|
|
gptkbp:contraindication
|
hypersensitivity
severe liver disease
|
|
gptkbp:developed_by
|
gptkb:Merck_&_Co.
|
|
gptkbp:discovered_by
|
1938
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
phenytoin
|
|
gptkbp:ingredients
|
C15 H12 N2 O2
|
|
gptkbp:interacts_with
|
gptkb:beer
gptkb:warfarin
oral contraceptives
|
|
gptkbp:is_available_in
|
tablets
suspension
capsules
|
|
gptkbp:is_available_on
|
generic drug
|
|
gptkbp:is_effective_against
|
febrile seizures
psychogenic non-epileptic seizures
|
|
gptkbp:is_monitored_by
|
liver function tests
complete blood count
serum levels
|
|
gptkbp:is_used_for
|
gptkb:psychologist
seizure prevention
|
|
gptkbp:lifespan
|
7 to 42 hours
|
|
gptkbp:manager
|
intravenous
intramuscular
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:release_region
|
gptkb:Australia
gptkb:India
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:rounds
|
urine
|
|
gptkbp:side_effect
|
dizziness
nausea
rash
osteoporosis
vitamin D deficiency
neuropathy
hirsutism
coarsening of facial features
gingival hyperplasia
|
|
gptkbp:suitable_for
|
absence seizures
myoclonic seizures
|
|
gptkbp:treatment
|
status epilepticus
focal seizures
neurosurgery-related seizures
post-traumatic seizures
tonic-clonic seizures
|
|
gptkbp:type_of
|
57-41-0
|